we are hereby submitting fresh corporate announcement as required after updating the required changes.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sharpline Broadcast Limited's board approved on February 11, 2025 the acquisition of 5,123 equity shares (51% stake) in Unayur Marketing Private Limited for a total cash consideration of Rs. 9 crore. Unayur, incorporated in 2019, operates in the Unani and Ayurvedic medicines, natural health products, cosmetics, and herbal products space, with a turnover of Rs. 66.30 crore in FY24 (Rs. 96.66 crore in FY23, Rs. 77.26 crore in FY22). The deal is not a related party transaction, needs no regulatory approvals, and is expected to complete within one month. Post-acquisition, Unayur will become a subsidiary of Sharpline. The company also clarified that the original disclosure was delayed due to an internal procedural lapse and was eventually uploaded on March 31, 2025.
This is a diversification move into the fast-growing Ayurvedic and herbal wellness sector, and Unayur's revenues will be consolidated into Sharpline's books, potentially boosting topline. The Rs. 9 Cr outlay for a 51% controlling stake in a company with Rs. 66+ Cr revenue looks reasonable, though the delayed regulatory disclosure may raise minor corporate governance concerns.